This trial will test a new, non-invasive way to measure pressure inside the skull, which could be helpful for patients with certain conditions.
1 Primary · 0 Secondary · Reporting Duration: Participants in the Healthy Control and Intra-Group Verification arms will be enrolled for one day. Transfer Function Estimation Subjects will be enrolled for up to 14 days.
90 Total Participants · 3 Treatment Groups
Primary Treatment: Video ophthalmoscope · No Placebo Group · N/A
Age Any Age · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: